161 results
Page 3 of 9
8-K
EX-99.1
1f2pt4szqswli1 y2jy
20 Oct 22
October 2022 Larimar Therapeutics Corporate Presentation
8:11am
424B5
puy pctq79do
14 Sep 22
Prospectus supplement for primary offering
7:28am
8-K
EX-99.2
9o0pvszfhzqjs9a7vb
14 Sep 22
Other Events
7:05am
8-K
EX-99.1
c5a9 2ix5r4tgz
14 Sep 22
Other Events
7:05am
8-K
EX-99.1
r72 qdhvlxksr2
11 Aug 22
Larimar plans to submit a complete response to CTI-1601’s clinical hold in the third quarter of 2022
4:13pm
8-K
EX-99.2
6vev3983y
11 Aug 22
Larimar plans to submit a complete response to CTI-1601’s clinical hold in the third quarter of 2022
4:13pm
8-K
EX-99.2
z242c 3fk
12 May 22
Larimar Therapeutics Reports First Quarter 2022 Operating and Financial Results
7:12am
8-K
EX-99.1
4bg90j
12 May 22
Larimar Therapeutics Reports First Quarter 2022 Operating and Financial Results
7:12am
8-K
EX-99.2
ongpdy05d4iu pux434
25 Mar 22
Larimar Therapeutics Reports Fourth Quarter and Full Year 2021 Operating and Financial Results
7:11am
8-K
EX-99.1
tdipqu kj
25 Mar 22
Larimar Therapeutics Reports Fourth Quarter and Full Year 2021 Operating and Financial Results
7:11am
8-K
EX-99.1
5mtms5
28 Feb 22
Results of Operations and Financial Condition
8:16am
8-K
EX-99.1
nv3jg8tlsfcen39q6az
14 Feb 22
Larimar Therapeutics Provides Update on CTI-1601 Clinical Program
12:00am
8-K
EX-99.1
qsdqwxs 3zrcb
12 Nov 21
Larimar Therapeutics Reports Third Quarter 2021 Operating and Financial Results
7:21am
8-K
EX-99.2
oj6vu4m04
12 Nov 21
Larimar Therapeutics Reports Third Quarter 2021 Operating and Financial Results
7:21am
8-K
EX-99.1
6a7xsps9c53td9g6vk1
12 Aug 21
Larimar Therapeutics Reports Second Quarter 2021 Operating and Financial Results
10:29am